New antifungal ent-labdane diterpenes against Candida glabrata produced by microbial transformation of ent-polyalthic acid

Candida glabrata, the most common non-albicans Candida species and one of the primary causes of candidemia, exhibits decreased susceptibility to azoles and more recently to echinocandins. Polyalthic acid 1, a furan diterpene, has been shown promising biological potential and in this study ent-polyalthic acid derivatives with antifungal activity against Candida glabrata were produced by microbial transformation. Incubation of 1 with Aspergillus brasiliensis afforded two known (compounds 5 and 10) and eight new derivatives (compounds 2-4, 6-9 and 11). The most common reaction was hydroxylation, but isomerization of the double bond and acetylation were also detected. None of the tested compounds showed cytotoxicity against HeLa, MCF-7 and MCF-10A cell lines showing IC50 values ranging from 62.6 mu M to > 500 mu M. Compounds 1, 5, 6, 8 and 11 showed fungistatic effects (ranging from 34.1 mu M to 39.5 mu M) on C. glabrata at lower concentrations than fluconazole (163.2 mu M). Compounds 1, 6 and 8 were more potent fungicides (ranging from 79.0 to 143.6 mu M) than fluconazole, which showed fungicidal effect at concentrations higher than 163.2 mu M. These results suggest that ent-polyalthic acid and some of its derivatives could be used as lead compounds to develop new antifungal agents